Lipase inhibitors

Details Lipase inhibitors Lipase inhibitors

2011-05-10

2011-05-10

Dentz, Bernard (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07939559

ABSTRACT:
The present invention provides lipase inhibitors containing flavan-3-ol monomers or acylates thereof derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of flavan-3-ol monomers represented by the formula:wherein R1and R3independently represent H or OH, R2represents H, R4represents H, G, 3MeG or p-cou, R5represents H or G, R4′ and R5′ independently represent H or G, R4″ represents H or G, and G, 3MeG and p-cou respectively represent the groups of the formulae:or acylates thereof; as well as foods and beverages and medicines containing said lipase inhibitors.

REFERENCES:
patent: 0522 502 (1993-01-01), None
patent: 60-011912 (1983-02-01), None
patent: H01-102022 (1989-04-01), None
patent: H2-23929 (1990-02-01), None
patent: H03-219872 (1991-09-01), None
patent: H03-228664 (1991-10-01), None
patent: H07-061927 (1995-03-01), None
patent: H08-259557 (1996-10-01), None
patent: H09-040689 (1997-02-01), None
patent: H09-291039 (1997-11-01), None
patent: 2000-226329 (1999-07-01), None
patent: 2000-226329 (2000-08-01), None
patent: 2002-080362 (2002-03-01), None
patent: 2002-104982 (2002-04-01), None
patent: 2003-095942 (2003-04-01), None
patent: WO 01/80870 (2001-11-01), None
Chantr et al,Phytochemistry vol. 9, (2002).
International Search Report issued Aug. 16, 2005, in application No. PCT/JP2005/012394, filed Jul. 5, 2005.
Supplementary European Search Report issued Dec. 18, 2009, in European Application No. EP 05 75 8209.0.
Hong et al., “Effects of Tea Polyphenols on Arachidonic Acid Metabolism in Human Colon,” in Food Factors in Health Promotion and Disease Prevention, Chapter 4, pp. 27-38, ACS Symposium Series, 200, vol. 851, American Chemical Society.
Yoshikawa et al., “Salacia reticulataand its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats,” Journal of Nutrition, 2002, vol. 132, No. 7, pp. 1819-1824.
Kumazawa, “Cha Seibun no Seitaimaku ni Taisuru Shinwasei (1)”, Cha, 2001, vol. 54, No. 2, pp. 36-37 (Japanese).
Shimada et al., “Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease,” J. Diabetes Research and Clinical Practice, 2004, vol. 65, pp. 227-234.
Chen et al., “Clinical Efficacy of Oolong Tea on Anti-Simple Obesity,” Journal of the Japanese Society of Clinical Nutrition, 1998, vol. 20, pp. 83-90 (English translation).
Moreno et al., “Inhibitory Effects of Grape Seed Extract on Lipases,” Nutrition, 2003, vol. 19, pp. 876-879.
Matsuda et al., “Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles,” Journal of Ethnopharmacology, Sep. 1986, vol. 17, No. 3, pp. 213-224.
Hashimoto et al., “Tannins and Related Compounds, XC,118-C-Ascorbyl (−)-Epigallocatechin 3-O-Gallate and Novel Dimeric Flavan-3-ols, Oolonghomobisflavans A and B, from Oolong Tea,” Chem. Pharm. Bull, 1989, vol. 37, No. 12, pp. 3255-3263.
Hashimoto et al., “Evaluation of the Anti-oxidative Effect (in vitro) of Tea Polyphenols,” Biosci. Biotechnol. Biochem., 2003, No. 67, vol. 2, pp. 396-401.
Mittal et al., “Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation,” Carcinogenesis, 2003, vol. 34, No. 8, pp. 1379-1388.
Nakai et al., “Inhibitory Effects of Oolong Tea Polyphenols on Pancreatic Lipase In Vitro,” Journal of Agricultural and Food Chemistry, 2005, vol. 53, pp. 4593-4598.
Han et al., “Anti-obesity action of oolong tea,” Int. J. Obes. Relat. Metab. Disord., Apr. 27, 1998, vol. 23, pp. 98-105.
Iwata et al., “Effect of Oolong Tea on Plasma Lipids and Lipoprotein Lipase Activity in Young Women,” J. Jpn. Soc. Nutr. Food Sci., 1991, vol. 44, No. 4, pp. 251-259 (English Translation).
Hashimoto et al., “Tannins and Related Compounds. LVI. Isolation of Four New Acylated Flavan-3-ols from Oolong Tea. (1),” Chem. Pharm. Bull, 1987, vol. 35, No. 2, pp. 611-616.

Affiliated with

Also associated with

Rating

Lipase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2669482